Clicky

Roche Holding AG(RO) News

Date Title
Jul 15 Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
Jul 14 HER2+ Gastric Cancer Market Analysis and Forecast Report 2025-2035: AstraZeneca, Merck, and Roche Lead Innovation in HER2+ Gastric Cancer Therapies
Jul 14 Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 | Advancements in Anti-VEGF Therapies Driving Progress in Treatments
Jul 12 FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
Jul 11 Smart Money Going in Senior Health: Key Stocks in Elderly Care
Jul 10 Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research
Jul 10 Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information
Jul 10 Danon Disease Treatment Modality Market Analysis and Forecasts 2025-2035 | Next-Gen Sequencing Speeds Up Danon Disease Diagnosis and Treatment Pathways
Jul 10 Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump
Jul 9 Will Recent Label Expansions of Opdivo Help BMY Gain Momentum?
Jul 9 Trump's Drug Tariffs: Where Does the U.S. Import Pharmaceuticals From?
Jul 9 Biomarkers Market Research Report 2025-2030 | Assay Kit Demand Surges as Advancements in Omics Technologies Elevate Biomarker Discovery and Diagnostic Precision
Jul 2 Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
Jun 30 Changes to the Roche Enlarged Corporate Executive Committee
Jun 27 Initiation of commercialization of ProNephro AKI (NGAL) for diagnostic use in the US
Jun 26 Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?
Jun 26 Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025
Jun 25 96% of health care executives are "ready and resourced" to use digital health solutions, yet two-thirds say interoperability is "a tough but manageable challenge," reveals new MIT Technology Review Insights report
Jun 23 Exelixis Surges On Positive Results For Next-Gen Colon Cancer Drug
Jun 23 Roche and Genentech’s Lunsumio-Polivy shows promise in Phase III trial